Literature DB >> 3921936

Fibrodysplasia ossificans progressiva: current concepts and the role of CT in acute changes.

D Lindhout, R P Golding, A H Taets van Amerongen.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) may be treated with diphosphonate in an attempt to control the deposition of calcium phosphate. Amounts of calcium deposition may be assayed by plain radiographs and CT. In a sporadic case of FOP treated for 6 years with a diphosphonate (EHDP) we have analyzed the findings from CT. This modality presents a suitable means of monitoring response to new therapeutic agents, but CT also gives insights into the pathogenesis of the disorder.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921936     DOI: 10.1007/bf02388618

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  10 in total

Review 1.  MYOSITIS OSSIFICANS PROGRESSIVA. MINERAL, METABOLIC AND RADIOACTIVE CALCIUM STUDIES OF THE EFFECTS OF HORMONES.

Authors:  L LUTWAK
Journal:  Am J Med       Date:  1964-08       Impact factor: 4.965

2.  A CONTRIBUTION TO THE STUDY OF MYOSITIS OSSIFICANS PROGRESSIVA.

Authors:  J Rosenstirn
Journal:  Ann Surg       Date:  1918-12       Impact factor: 12.969

3.  Paternal age effect in fibrodysplasia ossificans progressiva.

Authors:  J G Rogers; G A Chase
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

4.  Genetic aspects of fibrodysplasia ossificans progressiva.

Authors:  J M Connor; D A Evans
Journal:  J Med Genet       Date:  1982-02       Impact factor: 6.318

5.  The fetal hydantoin syndrome.

Authors:  J W Hanson; D W Smith
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

6.  Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains.

Authors:  P Sezzano; A Raimondi; M Arboix; C Pantarotto
Journal:  Mutat Res       Date:  1982-03       Impact factor: 2.433

7.  Phenytoin administration to pregnant mice: a mutagenic action?

Authors:  C Petter; M N Lombard; M Ehrensperger
Journal:  Biol Neonate       Date:  1981

8.  Myositis ossificans: diagnostic value of arteriography.

Authors:  I Yaghmai
Journal:  AJR Am J Roentgenol       Date:  1977-05       Impact factor: 3.959

9.  Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

Authors:  M D Francis; R G Russell; H Fleisch
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

10.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

  10 in total
  1 in total

Review 1.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.